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ABSTRACT  32 
The evolutionarily conserved centromeric histone H3 variant (Cse4 in budding yeast, CENP-A in 33 
humans) is essential for faithful chromosome segregation. Mislocalization of CENP-A to non-34 
centromeric chromatin contributes to chromosomal instability (CIN) in yeast, fly, and human 35 
cells and CENP-A is highly expressed and mislocalized in cancers. Defining mechanisms that 36 
prevent mislocalization of CENP-A is an area of active investigation. Ubiquitin-mediated 37 
proteolysis of overexpressed Cse4 (GALCSE4) by E3 ubiquitin ligases such as Psh1 prevents 38 
mislocalization of Cse4, and psh1Δ strains display synthetic dosage lethality (SDL) with 39 
GALCSE4. We previously performed a genome-wide screen and identified five alleles of CDC7 40 
and DBF4 that encode the Dbf4-dependent kinase (DDK) complex, which regulates DNA 41 
replication initiation, among the top twelve hits that displayed SDL with GALCSE4. We 42 
determined that cdc7-7 strains exhibit defects in ubiquitin-mediated proteolysis of Cse4 and 43 
show mislocalization of Cse4. Mutation of MCM5 (mcm5-bob1) bypasses the requirement of 44 
Cdc7 for replication initiation and rescues replication defects in a cdc7-7 strain. We determined 45 
that mcm5-bob1 does not rescue the SDL and defects in proteolysis of GALCSE4 in a cdc7-7 46 
strain, suggesting a DNA replication-independent role for Cdc7 in Cse4 proteolysis. The SDL 47 
phenotype, defects in ubiquitin-mediated proteolysis, and the mislocalization pattern of Cse4 in a 48 
cdc7-7 psh1Δ strain were similar to that of cdc7-7 and psh1Δ strains, suggesting that Cdc7 49 
regulates Cse4 in a pathway that overlaps with Psh1. Our results define a DNA replication 50 
initiation-independent role of DDK as a regulator of Psh1-mediated proteolysis of Cse4 to 51 
prevent mislocalization of Cse4. 52 
  53 
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INTRODUCTION 54 
The centromere, a specialized region of the chromosome that is essential for faithful 55 
chromosome segregation, and associated proteins make up the kinetochore, which serves as an 56 
attachment site for microtubules to promote segregation of sister chromatids during mitosis 57 
(ALLSHIRE AND KARPEN 2008; VERDAASDONK AND BLOOM 2011; BURRACK AND BERMAN 2012; 58 
CHOY et al. 2012; MADDOX et al. 2012; MCKINLEY AND CHEESEMAN 2016). Budding yeast 59 
“point centromeres” consist of approximately 125 base pairs (bp) of unique DNA sequences, 60 
whereas other eukaryotic organisms have “regional centromeres” consisting of several mega-bp 61 
of repeated DNA sequences, satellite DNA arrays, or retrotransposon-derived sequences. Despite 62 
the difference in the size of centromeres, the centromeric histone H3 variant (Cse4 in 63 
Saccharomyces cerevisiae, Cnp1 in Schizosaccharomyces pombe, CID in Drosophila 64 
melanogaster, and CENP-A in mammals) is evolutionarily conserved from yeast to human cells 65 
and is essential for faithful chromosome segregation (PRZEWLOKA AND GLOVER 2009; CHOY et 66 
al. 2012; HENIKOFF AND FURUYAMA 2012; BIGGINS 2013; WONG et al. 2020). Mislocalization of 67 
overexpressed CENP-A and its homologs to non-centromeric regions contributes to 68 
chromosomal instability (CIN) in yeast, fly, and human cells (HEUN et al. 2006; AU et al. 2008; 69 
MISHRA et al. 2011; LACOSTE et al. 2014; ATHWAL et al. 2015; SHRESTHA et al. 2017). CIN and 70 
high expression of CENP-A have been observed in cancer cells and this correlates with poor 71 
prognosis and increased invasiveness (TOMONAGA et al. 2003; AMATO et al. 2009; LI et al. 72 
2011; MCGOVERN et al. 2012; SUN et al. 2016; ZHANG et al. 2016). The mechanisms that 73 
prevent the mislocalization of CENP-A and its homologs are not fully understood. Defining 74 
these mechanisms will provide insight into how mislocalization of CENP-A contributes to 75 
aneuploidy in human cancers.   76 
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Stringent regulation of cellular levels of Cse4 by post-translational modifications such as 77 
ubiquitination prevents its mislocalization to non-centromeric regions in budding yeast, fission 78 
yeast, and flies (COLLINS et al. 2004; MORENO-MORENO et al. 2006; MORENO-MORENO et al. 79 
2011; AU et al. 2013; GONZALEZ et al. 2014). In addition to ubiquitination of Cse4, we have 80 
recently defined a role for sumoylation in proteolysis of Cse4 (OHKUNI et al. 2016). Multiple 81 
ubiquitin ligases, such as Psh1, Ubr1, the Sumo-targeted ubiquitin ligase Slx5, and the F-box 82 
protein Rcy1 regulate proteolysis of overexpressed Cse4 (HEWAWASAM et al. 2010; RANJITKAR 83 
et al. 2010; CHENG et al. 2016; OHKUNI et al. 2016; CHENG et al. 2017; OHKUNI et al. 2018). 84 
Psh1 is one of the best characterized E3 ligases for proteolysis of overexpressed Cse4 and 85 
prevents mislocalization of Cse4 to non-centromeric regions (HEWAWASAM et al. 2010; 86 
RANJITKAR et al. 2010). Psh1 interacts with the CENP-A targeting domain (CATD) in the C-87 
terminus of Cse4 (HEWAWASAM et al. 2010; RANJITKAR et al. 2010) and mediates Cse4 88 
degradation through the interaction of Psh1 with Spt16, a component of the FACT (facilitates 89 
chromatin transcription) complex (DEYTER AND BIGGINS 2014). It has also been shown that 90 
phosphorylation of Psh1 by casein kinase 2 (CK2) promotes degradation of Cse4 (HEWAWASAM 91 
et al. 2014). In addition to targeting the C-terminus of Cse4, we have shown that the N-terminus 92 
of Cse4 regulates Cse4 proteolysis (AU et al. 2013).  93 
Mutant strains that show defects in Cse4 proteolysis display synthetic dosage lethality 94 
(SDL) when Cse4 is overexpressed. However, Cse4 is not completely stabilized in psh1Δ, ubr1Δ, 95 
doa1Δ, slx5Δ, or rcy1Δ strains (CHENG et al. 2017), suggesting the existence of additional 96 
genes/pathways that regulate Cse4 proteolysis. We previously performed a Synthetic Genetic 97 
Array (SGA) using conditional mutant alleles of essential genes to identify additional factors that 98 
regulate Cse4 proteolysis (AU et al. 2020). The screen identified mutants encoding the F-box 99 
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proteins Met30 and Cdc4 of the Skp1, Cullin, F-box (SCF) complex. We defined a cooperative 100 
role for Met30 and Cdc4 in the proteolysis of endogenous Cse4 to prevent its mislocalization and 101 
promote chromosome stability (AU et al. 2020). Here, we pursued studies of the evolutionarily 102 
conserved Dbf4-dependent kinase (DDK) complex as we identified five mutant dbf4 and cdc7 103 
alleles among the top twelve significant SDL hits. The DDK complex, which is essential for the 104 
initiation of DNA replication, consists of the Cdc7 kinase and the regulatory subunit Dbf4 105 
(JACKSON et al. 1993; STILLMAN 1996). DDK promotes the initiation of DNA replication by 106 
phosphorylating Cdc45 and subunits of the mini-chromosome maintenance complex (Mcm2-7) 107 
at origins of replication (LEI et al. 1997; OWENS et al. 1997; ZOU AND STILLMAN 2000; BRUCK 108 
AND KAPLAN 2009). DDK also phosphorylates histone H3 at threonine 45 (H3T45) during S-109 
phase, which occurs in response to replication stress (BAKER et al. 2010), suggesting that H3T45 110 
phosphorylation is linked with DNA replication. Previous studies have shown that centromeric 111 
association of Cdc7 is important for early replication of centromeres (RAGHURAMAN et al. 2001; 112 
ROSSBACH et al. 2017), which are among the earliest firing origins.  113 
The identification of five cdc7 and dbf4 alleles that display SDL with overexpressed Cse4 114 
led us to investigate the role of DDK in regulating Cse4 proteolysis. We determined that Cdc7 115 
regulates Cse4 proteolysis in a pathway that overlaps with Psh1, and this prevents 116 
mislocalization of Cse4. The role of Cdc7 in Cse4 proteolysis is independent of its role in the 117 
initiation of DNA replication. 118 
  119 
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MATERIAL AND METHODS 120 
Strains and Plasmids 121 
Yeast strains were grown in YPD (1% yeast extract, 2% bacto-peptone, 2% glucose) or 122 
synthetic medium with glucose or raffinose/galactose (2% final concentration each) and 123 
supplements to allow for selection of the indicated plasmids. Yeast strains and plasmids used in 124 
this study are described in Table S1 and Table S2, respectively. To integrate the cdc7-7 allele 125 
marked with the G418 resistance marker (KanMX), the cdc7-7 sequence amplified from 126 
RSY302 and the KanMX sequence were cloned into pGEM-T-Easy. cdc7-7:KanMX from the 127 
vector was transformed into yeast strains as per standard lithium acetate procedure. 128 
Transformants were screened for temperature sensitivity at 37°C and sequenced (CCR Genomics 129 
Core) to confirm the G1137A mutation. Wild type CDC7 marked with G418 resistance strains 130 
were selected from the non-temperature sensitive transformants and sequenced to verify the wild 131 
type CDC7 sequence. To replace endogenous CSE4 with HA-tagged CSE4, a PCR-based method 132 
was used as described previously (BOECKMANN et al. 2013). Replacement of the CSE4 gene with 133 
HA-tagged CSE4 was verified by sequencing and Western blots confirmed the expression of the 134 
HA-tagged protein. At least two independent strains were analyzed for each experiment.  135 
 136 
Growth assays 137 
Wild type and mutant strains were transformed with the indicated plasmids or the empty 138 
vector. Transformants grown on synthetic medium, selective for the plasmid, were suspended in 139 
water to a concentration with an optical density of 1 measured at a wavelength of 600 nm 140 
(OD600, approximately 1.0 X 10
7 
cells per ml). Five-fold serial dilutions starting with 1 OD600 141 
were generated and 3 μl of each dilution spotted on synthetic growth medium selecting for the 142 
plasmid and containing either glucose (2% final concentration) or galactose and raffinose (2% 143 
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final concentration each). Strains were grown at the indicated temperatures for 3-5 days. Three 144 
independent transformants were assayed for growth unless otherwise stated. 145 
 146 
Protein stability assays  147 
Protein stability assays were performed as previously described (AU et al. 2008). Briefly, 148 
strains were grown to logarithmic phase overnight in selective media, re-suspended in fresh 149 
media containing galactose/raffinose (2% final concentration each) and grown for 1.75 or four 150 
hours as indicated in figure legends at 23°C. 10 µg/ml cycloheximide (CHX) and glucose (2% 151 
final concentration) were added to cultures and aliquots were collected 0, 30, 60, 90, and 120 152 
minutes after CHX addition. Proteins were isolated using the TCA method as described 153 
previously (KASTENMAYER et al. 2006). Protein levels were standardized using the Bio-Rad 154 
DC™ Protein Assay. Samples were diluted 1:1 with Laemmli buffer containing BME and stored 155 
at -20ºC for Western blot analysis. Proteins were separated by SDS-PAGE on 4-12% Bis-TRIS 156 
SDS-polyacrylamide gels (Novex, NP0322BOX). Western blot analysis was done using primary 157 
antibodies α-HA (1:1000, Roche, 12CA5), α-Flag (1:5000, Sigma, F3165), or α-Tub2 (1:4500, 158 
custom made for Basrai Laboratory) in TBST containing 5% (w/v) dried skim milk. HRP-159 
conjugated sheep α-mouse IgG (Amersham Biosciences, NA931V) and HRP-conjugated donkey 160 
α-rabbit IgG (Amersham Biosciences, NA934V) were used as secondary antibodies. Blots were 161 
washed after primary and secondary antibodies with TBST (Tris-buffered saline plus 0.1% 162 
Tween 20) three times for 10 minutes. Western blots were quantified with the SynGene program 163 
(SynGene, Cambridge, UK) or the Image Lab Software (BioRad). Protein stability of Cse4 was 164 
measured as the percent remaining after normalization to Tub2 signal. 165 
 166 
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Ubiquitination (Ub) Pull-down Assay 167 
Ub pull-down assays for determining the levels of ubiquitinated Cse4 were performed as 168 
described previously (AU et al. 2013) with minor modifications. Strains were grown to 169 
logarithmic phase overnight in selective media, re-suspended in fresh media containing 170 
galactose/raffinose (2% final concentration each) and grown for four hours at 23°C. Cells were 171 
resuspended in Cell Lysis Buffer with freshly added protease inhibitor cocktail, PMSF, and 172 
NEM (inhibitor for de-ubiquitination) and lysed by vortexing for 1 hour at 4°C in the presence of 173 
glass beads. The concentration of proteins in each resulting lysate was measured and normalized. 174 
50 µl lysate was saved for input and the remaining lysate was added to Tandem Ubiquitin 175 
Binding Entity (TUBE) beads (LifeSensors) and incubated overnight at 4ºC. Beads were 176 
centrifuged and washed three times with TBST on a rocking platform; unbound lysate was 177 
collected. Beads were resuspended in Laemmli buffer and incubated for 10 minutes at 100°C. 178 
Input and unbound fraction containing Laemmli buffer were processed in parallel. Samples were 179 
analyzed using Western Blot. Western blots were quantified with the SynGene program 180 
(SynGene, Cambridge, UK). p-value was determined using a paired t-test (GraphPad Prism). 181 
 182 
Chromosome spreads 183 
Chromosome spreads were performed as previously described (COLLINS et al. 2004; 184 
CROTTI AND BASRAI 2004; COLLINS et al. 2007) with minor modifications. Cultures were grown 185 
to logarithmic phase in selective medium containing 2% raffinose and treated with Nocodazole 186 
(20 µg/ mL final) for three hours to arrest cells in the G2/M phase of the cell cycle. FACS 187 
analysis confirmed the cell cycle arrest. For the last hour of the Nocodazole arrest, galactose was 188 
added to 2% final concentration. Cells were lysed gently by treatment with zymolase-100T and 189 
BME. Spheroplasts were then spread onto glass slides and fixed with paraformaldehyde and 1% 190 
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lipsol and allowed to air dry. Slides were washed with 1 X PBS for 10 minutes and incubated in 191 
16B12 Mouse anti-HA primary antibody (1:2500). Slides were washed three times with 1 X PBS 192 
for 10 min and incubated with Cy3 conjugated Goat anti-mouse secondary antibody (1:5000). 193 
Slides were washed with 1 X PBS and mounted with antifade containing DAPI and visualized 194 
using DeltaVision Microscopy Imaging Systems. Nuclei with a single or two HA- or Flag-Cse4 195 
foci were counted as normal Cse4 localization and nuclei with multiple foci or a diffused signal 196 
in the nucleus were counted as mislocalized Cse4. At least 360 cells were counted for each 197 
experiment. p-values were determined using Ordinary one-way ANOVA (GraphPad Prism) 198 
 199 
ChIP-Seq 200 
Chromatin immunoprecipitations were performed as previously described (COLE et al. 201 
2014; CHEREJI et al. 2017) with modifications. Cultures grown to logarithmic phase in glucose or 202 
raffinose/galactose media for 1.75 hours were treated with formaldehyde (final 1%) for 20 203 
minutes at 30°C followed by the addition of 2.5 M glycine for 10 minutes. Cells were washed 204 
twice with 1 X PBS and resuspended in 2 mL FA Lysis Buffer (1 mM EDTA pH8.0, 50 mM 205 
HEPES-KOH pH7.5, 140 mM NaCl, 0.1% sodium deoxycholate, 1% Triton X-100) with 1 x 206 
protease inhibitors (Sigma) and 1 mM PMSF final concentration. The cell suspension was split 207 
into four screw top tubes with glass beads (0.4-0.65 mm diameter) and lysed three times for 40 208 
seconds each, followed by a five-minute rest on ice, and lysed two times for 40 seconds each in 209 
an MP Bio FastPrep-24 5G. The cell lysate was collected, and the chromatin pellet was washed 210 
twice in FA Lysis Buffer. Each pellet was resuspended in 600 µl of FA Lysis Buffer and 211 
combined into one 5 ml tube. The chromatin suspension was sonicated 24 times with repeated 15 212 
seconds on/off at 20% amplitude using a Branson digital sonifer. After 3 minutes of 213 
centrifugation (13000 rpm, 4ºC), the supernatant was transferred to another tube. About 5% was 214 
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used for input and checking the size of sheared DNA. The remaining was incubated with 150 µl 215 
anti-FLAG® M2 Affinity Gel (Sigma, A2220-5ML) overnight. The beads were washed for five 216 
minutes on a rotator in 1 ml FA, FA-HS (500 mM NaCl), RIPA, and TE buffers twice each. The 217 
beads were resuspended in ChIP Elution Buffer (25 mM Tris-HCl pH7.6, 100 mMNaCl, 0.5% 218 
SDS) and incubated at 65°C overnight. The beads were treated with proteinase K (0.5 mg/ml) at 219 
55°C for four hours followed by Phenol/Chloroform extraction and ethanol precipitation. The 220 
DNA pellet was resuspended in a total of 50 µl sterile water. 221 
Input and IP samples were repaired using the NEB Pre-PCR Repair Mix (New England 222 
Biolabs, M0309). Paired-end libraries for input and IP samples were prepared using the 223 
NEBNext® End Prep (New England Biolabs, E7370) and NEBNext® Multiplex Oligos for 224 
Illumina (New England Biolabs, E7335). Agencourt AMPure XP beads (Beckman-Coulter, 225 
A63880) were used to purify adaptor-ligated DNA samples and PCR products (input adapters 226 
diluted 1/3 and IP 1/250). The 50-base paired-end Illumina reads were aligned to the S. 227 
cerevisiae S288C reference (R64-2-1) using Bowtie version 1.0.0 with command line options -n2 228 
-m1 -X 500. Duplicate reads (20-89%) were removed using Samtools rmdup (version 0.1.19). 229 
Between 1.4M and 5.3M unique alignments remained for the ChIP libraries and 14M-24M for 230 
the input libraries. The input alignments were randomly down sampled to 10M alignments each. 231 
Peaks were called using MACS (ZHANG et al. 2008) version 2.1.1.20160226 in paired-end mode 232 
with default parameters and no additional down sampling.  233 
The annotatePeaks tool of the Hypergeometric Optimization of Motif EnRichment suite 234 
(HOMER v5.10; http://homer.ucsd.edu/homer/) was used to assign peaks of Cse4 enrichment to 235 
genomic features. Customized annotations were utilized. Similar to the approach of Hildebrand 236 
and Biggins (HILDEBRAND AND BIGGINS 2016), 5’- and 3’-UTR’s were annotated using the data 237 
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of Nagalakshmi et al. (NAGALAKSHMI et al. 2008) downloaded from the yeast genome browser 238 
(https://browse.yeastgenome.org). 5’- and 3’-prime UTR data was available for 4605 and 5175 239 
genes, respectively. For genes lacking UTR data, UTR’s were assigned a median length (53 and 240 
105 nucleotides, respectively). Promoters were defined as the region lying 500 bp upstream of 241 
the transcription start site (i.e., position 1 of the 5’-UTR). Transcription termination sites were 242 
defined as ± 50 bp from the end of the 3’-UTR. 243 
Intersections between peak sets were computed using the IntersectRegions function of the 244 
USeq suite (http://useq.sourceforge.net) which also provides an estimate of statistical 245 
significance by randomization of one of the target peak sets across the genome. Coverage tracks 246 
were computed by MACS and normalized to 1M reads and displayed using the Integrative 247 
Genomics Viewer (ROBINSON et al. 2011). 248 
 249 
Data availability 250 
Strains and plasmids are available upon request. Supplemental file S1 contains Table S1, which 251 
describes the strains used in this study, and Table S2, which lists the plasmids used. Figures S1, 252 
S2, and S3 are available as supplemental files. Supplemental files are available at FigShare. 253 
ChIP-seq data for wild type and cdc7-7 strains with Flag-Cse4 expressed from its own promoter 254 
and GAL-Flag-Cse4 integrated into the genome are available at GEO with accession number 255 
GSE148068. 256 
  257 
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RESULTS 258 
Mutants of the Cdc7-Dbf4 kinase complex exhibit SDL with GALCSE4  259 
To identify mutants of essential genes that display synthetic dosage lethality (SDL) when 260 
Cse4 is overexpressed (GALCSE4), we performed a Synthetic Genetic Array (SGA) (AU et al. 261 
2020). A strain in which GAL-HA-CSE4 was integrated in the genome was mated to an array of 262 
786 conditional temperature sensitive strains. Growth at 26°C of the haploid meiotic progeny 263 
was scored on galactose plates and the p-value was determined as previously described 264 
(BARYSHNIKOVA et al. 2010; COSTANZO et al. 2010; COSTANZO et al. 2016). Among the top 265 
twelve hits that show SDL are five alleles of genes encoding the Dbf4-dependent kinase (DDK) 266 
complex, the gene encoding calmodulin, and regulators of proteasome assembly, mRNA 267 
polyadenylation, and cell cycle progression (Table 1). The identification of multiple alleles 268 
encoding components of the DDK complex led us to further investigate a possible role of DDK 269 
in regulating cellular levels of Cse4 to prevent mislocalization of Cse4 to non-centromeric 270 
regions. We confirmed the SDL phenotype using growth assays in which yeast strains 271 
transformed with a plasmid containing GALCSE4 or empty vector (vector) were plated on media 272 
with glucose or galactose to induce expression of GALCSE4. Strains with mutations in either 273 
CDC7 (Figure 1A; cdc7-4) or DBF4 (Figure 1A; dbf4-1, dbf4-2) exhibited GALCSE4 SDL at the 274 
permissive temperature of 23°C on galactose media. A cdc7-7 mutant, which was not included in 275 
the SGA screen, also exhibited GALCSE4 SDL (Figure 1A). We pursued in-depth studies with 276 
the cdc7-7 mutant because the cdc7-7 allele displays a stronger SDL phenotype at 23°C, has a 277 
low frequency of induced mutagenesis, does not have defects in the cell cycle at 23°C, and 278 
exhibits DNA replication defects only at the non-permissive temperature of 37°C 279 
(HOLLINGSWORTH JR et al. 1992). To establish that the SDL phenotype of a cdc7-7 GALCSE4 280 
strain is linked to the CDC7 gene, we performed growth assays with cdc7-7 GALCSE4 strains 281 
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with plasmid-borne CDC7 or empty vector. The plasmid-borne CDC7 rescued the temperature 282 
sensitivity of the cdc7-7 strain at 37°C and the SDL phenotype of cdc7-7 GALCSE4 at 23°C 283 
(Figure 1B). 284 
Cdc7 regulates ubiquitin-mediated proteolysis of Cse4 285 
Previous studies have shown that defects in ubiquitin-mediated proteolysis of 286 
overexpressed Cse4 contribute to GALCSE4 SDL in psh1∆, slx5∆, and hir2∆ strains 287 
(HEWAWASAM et al. 2010; RANJITKAR et al. 2010; OHKUNI et al. 2016; CIFTCI-YILMAZ et al. 288 
2018). The SDL phenotype of DDK mutants led us to hypothesize that proteolysis of Cse4 is 289 
regulated by the DDK complex. Therefore, we examined the stability of overexpressed HA-Cse4 290 
in wild type, cdc7-7, and dbf4-1 strains after treatment with cycloheximide at 23°C. Increased 291 
stability of HA-Cse4 was observed in cdc7-7 (Figure 2A) and dbf4-1 (Figure 2B) strains when 292 
compared to that in a wild type strain. 293 
It has been shown that defects in ubiquitination of Cse4 contribute to increased protein 294 
stability and mislocalization of Cse4 in a psh1Δ strain (HEWAWASAM et al. 2010; RANJITKAR et 295 
al. 2010). The increased stability of Cse4 led us to examine if a cdc7-7 strain exhibits defects in 296 
poly-ubiquitination of overexpressed HA-Cse4 (Ubn-Cse4). We performed an affinity pull-down 297 
of ubiquitinated proteins and consistent with previous studies (AU et al. 2013), we detected 298 
ubiquitinated Cse4 as a laddering pattern in wild type cells (Figure 2C). Quantification of signal 299 
intensities of Ubn-Cse4 normalized to signal intensities of Cse4 in input samples showed a 300 
significant reduction in the levels of ubiquitinated Cse4 in a cdc7-7 strain compared to a wild 301 
type strain (Figure 2C, p-value < 0.05). The defects in Cse4 proteolysis and Cse4 ubiquitination 302 
in the cdc7-7 strains suggest that Cdc7 regulates ubiquitin-mediated proteolysis of Cse4. 303 
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Cdc7 regulates proteolysis of Cse4 independently of its role in DNA replication initiation 304 
Previous studies have shown that DDK activates the initiation of DNA replication 305 
through phosphorylation of the MCM2-7 complex (LEI et al. 1997; OSHIRO et al. 1999; 306 
WEINREICH AND STILLMAN 1999; ZOU AND STILLMAN 2000; BRUCK AND KAPLAN 2009). DNA 307 
replication defects are observed in cdc7 strains at the non-permissive temperature of 37°C 308 
(SCLAFANI 2000), but DNA replication is unperturbed in cdc7-7 strains grown at 23°C (JACKSON 309 
et al. 1993). Mutation of proline 83 of MCM5 to leucine (mcm5-bob1) bypasses specifically the 310 
requirement of Cdc7 for replication initiation and rescues the temperature sensitivity and 311 
replication defects of cdc7-1 and cdc7-7 strains at 37°C (HARDY et al. 1997; SCLAFANI et al. 312 
2002; HOANG et al. 2007). We observed the GALCSE4 SDL phenotype and stability of HA-Cse4 313 
in cdc7-7 strains at 23°C. To further confirm that Cdc7-mediated proteolysis of Cse4 is 314 
independent of its role in initiating DNA replication, we performed growth assays for the SDL 315 
phenotype with the cdc7-7 mcm5-bob1 double mutant with GALCSE4. Our results showed that 316 
the cdc7-7 mcm5-bob1 GALCSE4 strain exhibited SDL similar to that observed in the cdc7-7 317 
GALCSE4 strain at 23°C (Figure 3A). Next, we determined if the mcm5-bob1 mutation affects 318 
the proteolysis of overexpressed HA-CSE4 in a cdc7-7 strain. Protein stability assays were done 319 
with extracts from wild type, cdc7-7, mcm5-bob1, and cdc7-7 mcm5-bob1 strains expressing 320 
GAL-HA-CSE4. The stability of HA-Cse4 in the mcm5-bob1 strain was similar to that of the wild 321 
type strain (Figure 3B). Furthermore, the defects in proteolysis of HA-Cse4 observed in the 322 
cdc7-7 strain were not suppressed in the cdc-7 mcm5-bob1 strain (Figure 3B). The inability of 323 
the mcm5-bob1 mutation to rescue the SDL phenotype and proteolysis defect in a cdc7-7 324 
GALCSE4 strain suggests that the role of Cdc7 in regulating Cse4 proteolysis is independent of 325 
Cdc7’s role in initiating DNA replication. 326 
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Cse4 is mislocalized to non-centromeric regions with an enrichment at promoters in a cdc7-327 
7 strain 328 
We next examined the localization pattern of Cse4 using chromosome spreads, a method 329 
that eliminates soluble material to visualize chromatin-bound HA-Cse4 in WT and cdc7-7 330 
strains. Previous studies have shown that Cse4 is localized to kinetochores that are clustered in 331 
one or two discrete nuclear foci in wild type cells, whereas mislocalization of Cse4 shows more 332 
than two foci or diffuse signal through the nuclear mass in psh1Δ, slx5Δ, and hir2Δ strains 333 
(HEWAWASAM et al. 2010; RANJITKAR et al. 2010; OHKUNI et al. 2016; CIFTCI-YILMAZ et al. 334 
2018). In the cdc7-7 strain, we found that, in contrast to wild type cells, HA-Cse4 was 335 
mislocalized with signal at more than two foci or diffused across the nuclear mass (Figure 4A 336 
and 4B, cdc7-7, p-value = 0.0028). To determine if the mislocalization of HA-Cse4 in a cdc7-7 337 
strain is due to a kinetochore clustering defect, we examined the localization of the kinetochore 338 
protein Mtw1-GFP (PINSKY et al. 2003; WESTERMANN et al. 2003). Our results showed a similar 339 
localization pattern of Mtw1-GFP to one or two foci in both the wild type (97.5%) and cdc7-7 340 
(94.6%) cells (Figure 4C and 4D). This suggests that the mislocalization of HA-Cse4 in a cdc7-7 341 
mutant is not due to kinetochore de-clustering. Based on these results, we conclude that DDK 342 
regulates ubiquitin-mediated proteolysis of Cse4 and prevents mislocalization of Cse4 to non-343 
centromeric regions. 344 
We next performed ChIP-seq experiments to define the genome-wide localization pattern 345 
of endogenous and overexpressed Cse4 in a cdc7-7 strain. ChIP-seq was performed using 346 
chromatin from wild type and cdc7-7 strains with endogenous Flag-Cse4 expressed from its own 347 
promoter grown at 23°C in glucose or with galactose-inducible Flag-Cse4 integrated in the 348 
genome and grown at 23°C in galactose media for 1.75 hours to overexpress Flag-Cse4. 349 
Consistent with previous reports (HILDEBRAND AND BIGGINS 2016), endogenous Flag-Cse4 350 
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showed peaks of enrichment primarily at centromeric (CEN) regions in the wild type strain 351 
(Figure S1, WT). Endogenous Flag-Cse4 also showed enrichment primarily at CEN regions in 352 
the cdc7-7 strain (Figure S1, cdc7-7), indicating that Flag-Cse4 expressed from its own promoter 353 
is not mislocalized to distinct non-centromeric genomic loci in a cdc7-7 strain. For 354 
overexpressed Flag-Cse4, at the sequencing depth of our experiments (1.5-5.3 million non-355 
duplicates, uniquely-mapped reads), Flag-Cse4 was found enriched at only 30 non-CEN sites in a 356 
wild type strain. In contrast, 2,187 non-CEN peaks of Flag-Cse4 were detected in a cdc7-7 GAL-357 
FLAG-CSE4 strain. In addition, a higher generalized background of Flag-Cse4 was observed 358 
across the genome as evidenced by a lower signal to noise ratio of the CEN peaks (Figure 5A, 359 
S2). Our results show that overexpressed Flag-Cse4 is highly enriched at promoters (60.4% of 360 
total peaks and 2.75-fold enriched relative to feature target size), but not at 3’-UTR’s, 361 
transcription termination sites (TTS), exons, introns, and intergenic regions in the cdc7-7 strain 362 
(Figure 5B). Significant enrichment (3.1-fold) was also found at 5’-UTR’s, although only 9.8% 363 
of the total peaks were found at these locations. This result is likely attributable to peaks 364 
overlapping the boundary between promoter and 5’-UTR. 365 
The phenotypes of SDL with GALCSE4, defects in Cse4 proteolysis, and mislocalization 366 
of Cse4 to non-centromeric regions in a cdc7-7 strain are similar to that observed in a psh1∆ 367 
strain (HEWAWASAM et al. 2010; RANJITKAR et al. 2010). Since the ChIP-seq experiments were 368 
performed with an isogenic set of strains with an integrated copy of GAL-FLAG-CSE4 in the 369 
same genetic background used previously to examine localization of overexpressed Flag-Cse4 in 370 
a psh1Δ background (HILDEBRAND AND BIGGINS 2016), we compared our results to the ChIP-seq 371 
results from Hildebrand and Biggins. The raw sequencing data was downloaded from the 372 
Sequence Read Archive (GEO Series GSE69696) and subjected to the same alignment and peak 373 
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calling procedures used for our ChIP-seq analyses with the cdc7-7 strain. Of the 2,129 regions of 374 
Flag-Cse4 enrichment identified in the cdc7-7 strain 2,059 (97%) overlapped with one or more 375 
peaks of Cse4 enrichment identified in the psh1Δ strain (p-value < 10-4) (Figure 5C). As 376 
observed for the psh1∆ strain, a high proportion (1,994/2,129, 94%) of Cse4 mislocalization in 377 
the cdc7-7 strain occurs in promoter regions (p-value < 10
-4
); virtually all were common to 378 
promoter-localized Cse4 found in the psh1Δ strain (Figure 5C). We note that in making the 3-379 
way comparison, closely-spaced peaks are merged to eliminate inconsistency in counts when a 380 
single peak in one set overlaps multiple peaks in another set; thus, the total number of intervals 381 
shown in Figure 5C differs from the actual cdc7-7 peak count indicated in Figure 5B. Overall, 382 
these results show that the mislocalization pattern of Cse4 in the cdc7-7 strain is similar to that 383 
observed in a psh1∆ strain. 384 
Cdc7 regulates Psh1-mediated proteolysis of overexpressed Cse4 385 
We have previously shown that overexpression of the ubiquitin-encoding gene UBI4 386 
suppresses the SDL of a psh1Δ GALCSE4 strain (AU et al. 2013). The overlapping pattern of 387 
Cse4 mislocalization in cdc7-7 and psh1∆ strains prompted us to examine if overexpression of 388 
UBI4 would suppress the SDL of a cdc7-7 GALCSE4 strain. Growth assays showed that UBI4 389 
suppresses the cdc7-7 GALCSE4 SDL phenotype at the permissive temperature of 23°C (Figure 390 
6A). UBI4 did not suppress the TS growth defect of cdc7-7 strains at 37°C.  391 
We took multiple approaches to evaluate if Cdc7 functions in an overlapping pathway 392 
with Psh1 to regulate Cse4 proteolysis. We generated cdc7-7 and psh1∆ single and cdc7-7 psh1∆ 393 
double mutant strains with GAL-FLAG-CSE4 integrated in the genome. Growth assays 394 
confirmed the SDL phenotype of GAL-FLAG-CSE4 for cdc7-7 (Figure 1A and 6B), and that 395 
reported previously for psh1∆ strains on galactose media (HEWAWASAM et al. 2010; RANJITKAR 396 
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et al. 2010). The psh1∆ strain showed a more severe growth defect than the cdc7-7 strain with 397 
GAL-FLAG-CSE4. The cdc7-7 psh1∆ double mutant displays SDL similar to that observed for 398 
the psh1∆ strain (Figure 6B). We also examined the stability of overexpressed Flag-Cse4 in the 399 
cdc7-7, psh1∆, and cdc7-7 psh1∆ strains. Consistent with previous results (Figure 2A and 400 
(HEWAWASAM et al. 2010; RANJITKAR et al. 2010)), Flag-Cse4 was more stable in cdc7-7 and 401 
psh1∆ strains when compared to the wild type strain (Figure 6C). The stability of Flag-Cse4 in 402 
the psh1Δ strain is higher than that in the cdc7-7 strain, however the stability of Flag-Cse4 in the 403 
cdc7-7 psh1∆ strain was similar to that observed in the psh1∆ strain (Figure 6C). Lastly, we 404 
examined the mislocalization of Flag-Cse4 in wild type, cdc7-7, psh1∆, and cdc7-7 psh1∆ strains 405 
using chromosome spreads. We observed significantly higher levels of Flag-Cse4 406 
mislocalization in cdc7-7 as described earlier (Figures 4A and 4B) and as reported previously for 407 
psh1∆ strains (HEWAWASAM et al. 2010; RANJITKAR et al. 2010) when compared to the wild 408 
type strain. Consistent with results for the SDL phenotype and protein stability, the 409 
mislocalization of Flag-Cse4 was not further enhanced in cdc7-7 psh1∆ strains when compared 410 
to the single cdc7-7 and psh1∆ strains (Figure 6D, p-value > 0.999). We propose that Cdc7 and 411 
Psh1 are epistatic for proteolysis of Cse4 to prevent Cse4 mislocalization to non-centromeric 412 
regions. 413 
  414 
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DISCUSSION 415 
In this study, we investigated the role of the Dbf4-dependent kinase (DDK) complex in 416 
proteolysis of Cse4. Five alleles of genes encoding DDK were among the top twelve hits in a 417 
screen to identify mutant strains displaying SDL with GALCSE4. Our results show that cdc7-7 418 
strains exhibit an SDL phenotype with GALCSE4, defects in ubiquitin-mediated proteolysis of 419 
Cse4, and mislocalization of Cse4 to non-centromeric regions, particularly to gene promoters. 420 
The lack of a rescue of the GALCSE4 SDL or Cse4 proteolysis defect in the cdc7-7 strain by 421 
mcm5-bob1 indicates a DNA replication-independent role of Cdc7 in Cse4 proteolysis. 422 
Additionally, several experimental approaches showed that Cdc7 functions in a pathway 423 
overlapping with Psh1 to promote proteolysis of Cse4 and prevent Cse4 mislocalization to non-424 
centromeric regions. Our studies define the first essential kinase, DDK, to regulate proteolysis of 425 
overexpressed Cse4 and prevent mislocalization of Cse4. 426 
DDK is most well-studied for its role in initiating DNA replication through 427 
phosphorylation of the MCM2-7 DNA helicase complex at origins of replication, allowing cells 428 
to proceed through the G1/S phase of the cell cycle (LEI et al. 1997; OSHIRO et al. 1999; 429 
WEINREICH AND STILLMAN 1999; ZOU AND STILLMAN 2000; BRUCK AND KAPLAN 2009). 430 
Temperature sensitive cdc7 mutants exhibit defects in the cell cycle and are unable to complete 431 
DNA replication at the restrictive temperature of 37°C; replication and cell cycle defects are not 432 
observed at the permissive temperature of 23°C (reviewed in (SCLAFANI 2000)). All the assays in 433 
our current study, including growth, protein stability, and chromosome localization, were 434 
performed at 23°C. Based on these results, we conclude that the GALCSE4 SDL phenotype, 435 
defect in Cse4 proteolysis, and decrease in Ubn-Cse4 levels in cdc7-7 strains observed at 23°C 436 
are independent of defects in cell cycle progression. 437 
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Phosphorylation of MCM2-7 by DDK causes a conformational change in the MCM2-7 438 
complex  and this regulates replication initiation (HOANG et al. 2007). A mutation in MCM5, 439 
P83L (mcm5-bob1), is thought to mimic the conformational change that results from DDK-440 
mediated phosphorylation of MCM2-7. The mcm5-bob1 mutation rescues the temperature 441 
sensitivity, bypasses the cell cycle defects of cdc7 strains (JACKSON et al. 1993), and the DNA 442 
distribution by FACS of a cdc7 mcm5-bob1 strain is normal (HARDY et al. 1997). We used 443 
genetic and biochemical approaches to examine if the role of Cdc7 in proteolysis of Cse4 is 444 
independent of its role in replication initiation. We reasoned that if the regulation of Cse4 445 
proteolysis by Cdc7 was dependent on replication initiation, the mcm5-bob1 mutation should 446 
rescue the SDL phenotype and Cse4 proteolysis defect in cdc7-7 strains. However, we did not 447 
observe suppression of the GALCSE4 SDL or defects in Cse4 proteolysis in the cdc7-7 mcm5-448 
bob1 strain at 23°C. Furthermore, ChIP-seq using a cdc7-7 strain did not reveal a significant 449 
enrichment of Cse4 to origins of DNA replication which are normally occupied by Cdc7 450 
(ROSSBACH et al. 2017). Similar to our observations, a previous study has shown that mcm5-451 
bob1 cannot suppress the defect of cdc7-induced mutagenesis (PESSOA-BRANDAO AND SCLAFANI 452 
2004), indicating a different Cdc7 substrate in mutagenesis than the MCM2-7 complex 453 
(ROSSBACH AND SCLAFANI 2016). Together, our results support a DNA replication-independent 454 
role of Cdc7 in regulating Cse4 proteolysis. 455 
Cse4 expressed from its own promoter is not detectably mislocalized to specific genomic 456 
regions in a cdc7-7 strain (Figure S1). Additionally, degradation of endogenous Flag-Cse4 in a 457 
cdc7-7 strain is similar to that in a wild type strain (Figure S3). Genome-wide studies have 458 
shown that mislocalization of Cse4 is barely detectable in wild type (CAMAHORT et al. 2009; 459 
LEFRANCOIS et al. 2009; HILDEBRAND AND BIGGINS 2016) or psh1Δ strains (HILDEBRAND AND 460 
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BIGGINS 2016), suggesting that cellular levels of endogenous Cse4 are stringently regulated to 461 
ensure that it is not mislocalized to non-centromeric regions in a wild type cell. In the context of 462 
overexpressed Cse4, wild type cells do not show growth inhibition with GAL-CSE4, in part 463 
because overexpressed Cse4 is proteolyzed by Psh1, Rcy1, Slx5, Ubr1, and other regulators. 464 
Mutants of these regulators display defects in proteolysis of Cse4, which contributes to 465 
mislocalization of overexpressed Cse4 and lethality with GAL-CSE4 (HEWAWASAM et al. 2010; 466 
RANJITKAR et al. 2010; OHKUNI et al. 2016; CIFTCI-YILMAZ et al. 2018). 467 
Our studies here provide evidence that Cdc7 plays a role in regulating levels of 468 
overexpressed Cse4. Chromosome spreads showed mislocalization of overexpressed Cse4 in a 469 
cdc7-7 strain and ChIP-seq confirmed these results. We observed a significant amount of Cse4 470 
mislocalization throughout the genome, and analysis of the localization pattern showed a 471 
preferential enrichment of Flag-Cse4 at promoter regions with a high degree of overlap to that 472 
observed in the psh1Δ strain. We propose that Cdc7 functions in a pathway that overlaps with 473 
Psh1 in Cse4 proteolysis. We provide several lines of evidence to support our hypothesis. The 474 
GALCSE4 SDL phenotype, increased stability of Cse4, and levels of Cse4 mislocalization 475 
observed in the cdc7-7 psh1Δ strain were not significantly different than that observed in the 476 
cdc7-7 or psh1∆ strains. Additionally, the preferential localization of Cse4 to promoters is 477 
observed in both cdc7-7 and psh1Δ strains and the GALCSE4 SDL phenotype is suppressed by 478 
overexpression of UBI4 in both cdc7-7 and psh1∆ strains. Future studies will allow us to 479 
investigate the mechanism by which Cdc7 affects the Psh1 pathway and if Cdc7 regulates 480 
pathways other than Psh1-mediated proteolysis for Cse4. 481 
Previous studies have shown that Cdc7 and Dbf4 associate with replication origins, 482 
including the early-firing replication origins at the centromere (NATSUME et al. 2013; ROSSBACH 483 
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et al. 2017) and that low levels of DDK at centromeres contributes to delay in the replication of 484 
centromeres (NATSUME et al. 2013). DDK associates with kinetochores through the COMA 485 
complex, consisting of Ctf19, Mcm21, Okp1, and Ame1, and this regulates sister chromatid 486 
cohesion independently of the role of DDK in initiating DNA replication (NATSUME et al. 2013). 487 
DDK phosphorylates the N-terminal tail of Ctf19 and this recruits the cohesin loader Scc2/4, for 488 
proper sister chromatid cohesion (HINSHAW et al. 2017). Recent studies have shown that the N-489 
terminal tail of Cse4 interacts with Okp1, which directs kinetochore loading distinct from Mif2-490 
directed loading (FISCHBÖCK-HALWACHS et al. 2019). Phosphorylation of the N-terminal tail of 491 
Cse4 promotes the interaction of Cse4 with Ame1/Okp1 and this likely regulates recruitment of 492 
kinetochore components (HINSHAW AND HARRISON 2019). It is of great interest to examine if 493 
Cse4 is a substrate of DDK and define the role of DDK-mediated phosphorylation of Ctf19 for 494 
the association of the COMA complex with Cse4. Future studies will allow us to examine if 495 
DDK-mediated phosphorylation of kinetochore substrates such as Cse4, Psh1, and Ctf19 496 
contribute to the proteolysis of overexpressed Cse4 and prevent its mislocalization to non-497 
centromeric regions. 498 
In this study, we have described a new role for the essential kinase Cdc7 in regulating 499 
Psh1-mediated proteolysis of Cse4 independently of Cdc7’s role in initiating DNA replication. 500 
Based on our results for SDL of GALCSE4 in cdc7-7 strains, we propose that inhibition of Cdc7 501 
in cancers with high levels of CENP-A would lead to cancer cell-specific cell death. These 502 
studies are relevant from a clinical standpoint because high levels of Cdc7 and Dbf4 expression 503 
have been reported in several types of cancers (BONTE et al. 2008) and this correlates with 504 
accelerated progression through the cell cycle, mutation of p53, resistance to DNA damaging 505 
agents and chemotherapy, and poor survival rates (MONTAGNOLI et al. 2004; BONTE et al. 2008; 506 
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KULKARNI et al. 2009; RODRIGUEZ-ACEBES et al. 2010; HOU et al. 2012; CHENG et al. 2013). 507 
Targeting Cdc7 through siRNA knockdown in cancer cells has been shown to result in cancer 508 
cell-specific apoptotic cell death (BONTE et al. 2008; KULKARNI et al. 2009; HOU et al. 2012), 509 
whereas non-cancerous cells arrest in G1 and resume proliferation after Cdc7 activity is restored 510 
(RODRIGUEZ-ACEBES et al. 2010). Currently, Cdc7 inhibitors are in clinical trials to 511 
downregulate Cdc7 activity in cancer cells (clinicaltrials.gov #’s NCT02699749, 512 
NCT03096054). The evolutionary conservation of CENP-A and DDK makes budding yeast an 513 
excellent model to investigate the molecular role of DDK in preventing mislocalization of 514 
CENP-A and CIN.  515 
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TABLE 531 
Table 1. Twelve mutant alleles with the lowest score from a Synthetic Genetic Array (SGA) 532 
with temperature sensitive gene mutants overexpressing CSE4. Listed are the top twelve 533 
conditional alleles of essential genes that displayed SDL when CSE4 is expressed from a 534 
galactose-inducible promoter (AU et al. 2020). Shown are the mutant allele, SGA score as the 535 
epsilon value calculated as previously in (COSTANZO et al. 2010; COSTANZO et al. 2016) with a 536 
negative value indicating a defect in growth, human orthologue 537 
(https://yeastmine.yeastgenome.org/yeastmine), and gene ontology (GO) annotation 538 
(https://www.yeastgenome.org/).  539 
 
Mutant SGA score Human orthologue GO Category 
1 cdc7-4  -1.348 CDC7 
 DNA-dependent DNA replication 
initiation 
2 dbf4-2  -1.22 DBF4 
 DNA-dependent DNA replication 
initiation 
3 dbf4-ts  -1.206 DBF4 
 DNA-dependent DNA replication 
initiation 
4 gpi12-ph  -1.13 PIGL  GPI anchor biosynthetic process 
5 cdc23-1  -1.113 CDC23 
 Regulation of mitotic 
metaphase/anaphase transition 
6 cmd1-1  -1.031 CALML3/5 
 Phosphatidylinositol biosynthetic 
process 
7 dbf4-1  -0.989 DBF4 
 DNA-dependent DNA replication 
initiation 
8 sts1-ph  -0.975 
 
 Proteasome localization 
9 hrp1-1  -0.94 HNRNPA2B1  mRNA polyadenylation 
10 rna15-58  -0.937     mRNA polyadenylation 
11 cdc7-1  -0.927  CDC7 
  DNA-dependent DNA replication 
initiation 
12  pre2-75  -0.916  PSMB11   Proteasome core complex assembly 
  540 
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FIGURES LEGENDS 541 
Figure 1. DDK mutants exhibit synthetic dosage lethality (SDL) to GALCSE4. A. 542 
Validation of GALCSE4 SDL in cdc7 and dbf4 strains. Growth assays were done with wild 543 
type [BY4741 (for cdc7-4, dbf4-1, and dbf4-2) and RSY299 (for cdc7-7)], cdc7-4 (tsa131), dbf4-544 
1 (tsa161), dbf4-2 (tsa162), and cdc7-7 (RSY302) strains transformed with vector (pMB433, 545 
vector) or GAL-HA-CSE4 (SB878, GALCSE4). Cells were spotted in five-fold serial dilutions on 546 
medium selective for the plasmid containing either glucose (2%, Cse4 expression off) or 547 
raffinose/galactose (2% each, Cse4 expression is on) and incubated at 23°C for 3-5 days. Two 548 
independent transformants of dbf4-1, dbf4-2, and cdc7-4 strains and three independent 549 
transformants of cdc7-7 strains were assayed and a representative image is shown. B. The 550 
GALCSE4 SDL phenotype of a cdc7-7 strain is linked to the cdc7 mutant allele. Growth 551 
assays were done with cdc7-7 strains (RSY302 with pMB433 and RSY302 with pMB1597) 552 
transformed with empty vector (pRS425) or plasmid-born CDC7 (pMB1898). Cells were spotted 553 
in five-fold serial dilutions on medium selective for the plasmids with glucose (2%) or 554 
raffinose/galactose (2% each). Plates were incubated at the indicated temperature for 5-7 days. 555 
Three independent transformants for each strain were assayed and a representative image is 556 
shown. 557 
  558 
Figure 2. Cdc7 regulates ubiquitin-mediated proteolysis of Cse4. A. Cse4 is stabilized in a 559 
cdc7 strain and B. Cse4 is stabilized in a dbf4 strain. Western blot analysis of protein extracts 560 
prepared from wild type (BY471 for dbf4-1 and RSY299 for cdc7-7), (A) cdc7-7 (RSY302), and 561 
(B) dbf4-1 (TSA161) strains transformed with GAL-HA-CSE4 (pMB1597). Strains were grown 562 
to logarithmic phase of growth in raffinose-containing media (2%), and expression of GAL-HA-563 
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CSE4 was induced with galactose (2%) for four hours. Cells were then treated with 564 
cycloheximide (CHX, 10 µg/ml) and glucose (2%). Aliquots were taken at the indicated 565 
timepoints. Protein extracts were analyzed using Western blot analysis and blots were probed 566 
with anti-HA (Cse4) and anti-Tub2. (loading control). Quantification of the levels of HA-Cse4 567 
remaining after treatment with CHX relative to Tub2 from two independent experiments is 568 
shown in the graphs. Error bars represent SEM. C. Ubiquitination of Cse4 is decreased in a 569 
cdc7 strain. Ub-pull down assays were performed using protein extracts from wild type and 570 
cdc7-7 strains as described above and lysates were incubated with Tandem Ubiquitin Binding 571 
Entity beads (LifeSensors). Input and ubiquitin-enriched (Pull down: Ub
+
) samples were 572 
analyzed via Western blot against HA (left). Arrow indicates the unmodified Cse4 band. 573 
Quantification of levels of poly-ubiquitinated Cse4 (Ubn-Cse4) normalized to the levels in the 574 
input from three independent experiments is shown in the graph, p-value < 0.05.  575 
 576 
Figure 3. Cdc7 regulates stability of Cse4 independently of its role in initiation of DNA 577 
replication. A. A cdc7-7 mcm5-bob1 strain shows SDL with GALCSE4. Growth assays with 578 
wild type (RSY299), mcm5-bob1 (RSY867), cdc7-7 (RSY302), or cdc7-7 mcm5-bob1 (RSY847) 579 
strains transformed with vector (pMB433, vector) or GAL-HA-CSE4 (SB878, GALCSE4). Cells 580 
were spotted in five-fold serial dilutions on media selective for the plasmid containing either 581 
glucose (2%) or raffinose/galactose (2% each) and incubated at 23°C for 3-5 days. Three 582 
independent transformants for each strain were assayed and the representative image is shown. 583 
B. A cdc7-7 mcm5-bob1 strain exhibits defects in Cse4 proteolysis. Western blot analysis of 584 
protein extracts from wild type (RSY299), mcm5-bob1 (RSY867), cdc7-7 (RSY302), or cdc7-7 585 
mcm5-bob1 (RSY847) strains transformed with GAL-HA-CSE4 (pMB1597). Strains were grown 586 
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to logarithmic phase of growth in raffinose-containing media (2%) and expression of GAL-HA-587 
CSE4 was induced with galactose (2%) for four hours. Cells were then treated with 588 
cycloheximide (CHX, 10 µg/ml) and glucose (2%). Aliquots were taken at the indicated 589 
timepoints. Protein extracts were analyzed using Western blot analysis and blots were probed 590 
with anti-HA (Cse4) and anti-Tub2. (loading control). The graph shows the quantification of 591 
levels of HA-Cse4 remaining after treatment with CHX relative to Tub2 from two independent 592 
experiments. Error bars represent SEM. 593 
 594 
Figure 4. Cdc7 prevents mislocalization of Cse4 to non-centromeric regions. A. Cse4 is 595 
mislocalized in a cdc7 strain. Localization of Cse4 was examined using chromosome spreads 596 
prepared from nocodazole arrested wild type (RSY299) and cdc7-7 (RSY302) strains 597 
transformed with GAL-HA-CSE4 (pMB1597). HA-Cse4 was labeled with Cy3 (red) and DNA 598 
with DAPI (blue). Representative images of cells showing normal localization counted as nuclei 599 
with one or two Cse4 foci (WT) and mislocalization counted as nuclei with more than two foci 600 
or a diffuse signal in the nucleus (cdc7-7). Arrow indicates HA-Cse4 foci. B. Quantification of 601 
Cse4 localization from A. The graph displays the quantification of Cse4 localization as a 602 
percentage over total cell count. The SEM of two independent experiments is shown, WT 1 or 2 603 
foci vs cdc7-7 1 or 2 Foci p-value = 0.0028; WT 3+ foci vs cdc7-7 3+ Foci p-value = 0.0028. C. 604 
The kinetochore protein Mtw1 is not mislocalized in a cdc7-7 strain. Wild type (YMB9337) 605 
and cdc7-7 (YMB9338) cells were transformed with Mtw1-GFP on a plasmid (pMB1058), 606 
grown to logarithmic phase of growth, and analyzed for Mtw1-GFP (green) foci with live cell 607 
imaging. Representative images of cells showing single Mtw1-GFP foci are shown. Arrow 608 
indicates Mtw1-GFP foci. D. Quantification of Mtw1-GFP localization from C. The graph 609 
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displays the quantification of cells with one or two GFP foci (normal) or with greater than three 610 
foci (mislocalized) with the SEM of two independent experiments; WT 1 or 2 foci vs cdc7-7 1 or 611 
2 Foci p-value = 0.1683; WT 3+ foci vs cdc7-7 3+ Foci p-value = 0.1683. 612 
 613 
Figure 5. Cse4 is mislocalized to non-centromeric regions in a cdc7-7 strain. ChIP-seq was 614 
performed using chromatin lysates from wild type (YMB10044) and cdc7-7 (YMB10041) 615 
strains. A. Flag-Cse4 is mislocalized in a cdc7-7 strain. Genome browser of input and ChIP 616 
samples for Chromosome I and Chromosome V in wild type (top) and cdc7-7 (bottom) strains 617 
overexpressing Flag-Cse4. Regions of CEN1 and CEN5 are shown. B. Flag-Cse4 is enriched at 618 
promoters in a cdc7-7 strain. The annotatePeaks tool of HOMER v5.10 619 
(http://homer.ucsd.edu/homer/) was used to define genomic locations of Flag-Cse4 enrichment in 620 
the cdc7-7 strain. The genomic feature, peak number, percent of total peaks, region size, fold-621 
enrichment (relative to sequence content), and LogP enrichment are indicated. C. FLAG-Cse4 is 622 
preferentially enriched at promoters in cdc7-7 and psh1Δ strains. Overlap between Flag-623 
Cse4 enrichment in cdc7-7 and psh1Δ strains and at promoters. 624 
 625 
Figure 6. Cdc7 regulates Psh1-mediated proteolysis of Cse4. A. Overexpression of UBI4 626 
suppresses the SDL of a cdc7-7 GALCSE4 strain. Growth assays of wild type (RSY299) and 627 
cdc7-7 (RSY302) cells transformed with empty vector (pMB433, GALCSE4 -) or GAL-HA-CSE4 628 
(pMB1597, GALCSE4+) and subsequently transformed with empty (pRS425, 2µ UBI4-) or 629 
UBI4 (pMB1604, UBI4+). Cells were spotted in five-fold serial dilutions on media selective for 630 
the plasmids containing either glucose (2%) or raffinose/galactose (2% each) and incubated at 631 
23°C or 37°C as indicated for 3-5 days. Three independent transformants for each strain were 632 
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assayed and the representative image is shown. B. The GALCSE4 SDL phenotype of the cdc7-633 
7 psh1∆ strain is similar to that observed for psh1∆ and cdc7-7 strains. Growth assays of 634 
wild type, psh1∆, cdc7-7, and cdc7-7 psh1∆ strains with endogenously expressed Flag-Cse4 635 
(vector; YMB10043, YMB10126, YMB10040, and YMB10124, respectively) or Flag-Cse4 636 
expressed from a galactose-inducible promoter integrated into the genome (GALCSE4; 637 
YMB10044, YMB10127, YMB10041, and YMB10125, respectively) spotted in five-fold serial 638 
dilutions on to rich media containing either glucose (2%) or raffinose/galactose (2% each) and 639 
incubated at 23°C for 5 days. Three independent transformants for each strain were assayed and 640 
the representative image is shown. C. The Cse4 proteolysis defect in a cdc7-7 psh1∆ double 641 
mutant is similar to that observed for a psh1∆ strain. Western blot analysis of protein extracts 642 
from wild type (YMB10044), cdc7-7 (YMB10041), psh1∆ (YMB10127), and cdc7-7 psh1∆ 643 
(YMB10125) strains grown to logarithmic phase of growth in raffinose-containing media (2%). 644 
Expression of GAL-FLAG-CSE4 was induced with galactose (2%) for 1.75 hours. Cells were 645 
then treated with cycloheximide (CHX, 10 µg/ml) and glucose (2%). Aliquots were taken at the 646 
indicated timepoints. Protein extracts were analyzed using Western blot analysis and blots were 647 
probed with anti-FLAG (Cse4) and anti-Tub2. (loading control). The graph shows the 648 
quantification of the levels of FLAG-Cse4 remaining after treatment with CHX relative to Tub2 649 
from two independent experiments. Error bars represent SEM. D. Mislocalization of Cse4 is not 650 
further enhanced in the cdc7-7 psh1∆ strain. Localization of Cse4 was examined using 651 
chromosome spreads prepared from nocodazole arrested wild type (YMB10044), cdc7-7 652 
(YMB10041), psh1∆ (YMB10127), and cdc7-7 psh1∆ (YMB10125). FLAG-Cse4 was labeled 653 
with Cy3 and DNA with DAPI. The graph displays quantification of Cse4 localization as a 654 
percentage over total cell count. The graph displays the SEM of two independent experiments, 655 
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psh1Δ 3+ foci vs cdc7-7 3+ Foci, cdc7-7 3+ foci vs cdc7-7 psh1Δ 3+ Foci, and psh1Δ 3+ foci vs 656 
cdc7-7 psh1Δ 3+ Foci p-value > 0.999.   657 
33 
 
 658 
CITATIONS 659 
Allshire, R. C., and G. H. Karpen, 2008 Epigenetic regulation of centromeric chromatin: old 660 
dogs, new tricks? Nat Rev Genet 9: 923-937. 661 
Amato, A., T. Schillaci, L. Lentini and A. Di Leonardo, 2009 CENPA overexpression promotes 662 
genome instability in pRb-depleted human cells. Mol Cancer 8: 119. 663 
Athwal, R. K., M. P. Walkiewicz, S. Baek, S. Fu, M. Bui et al., 2015 CENP-A nucleosomes 664 
localize to transcription factor hotspots and subtelomeric sites in human cancer cells. 665 
Epigenetics Chromatin 8: 2. 666 
Au, W. C., M. J. Crisp, S. Z. DeLuca, O. J. Rando and M. A. Basrai, 2008 Altered dosage and 667 
mislocalization of histone H3 and Cse4p lead to chromosome loss in Saccharomyces 668 
cerevisiae. Genetics 179: 263-275. 669 
Au, W. C., A. R. Dawson, D. W. Rawson, S. B. Taylor, R. E. Baker et al., 2013 A Novel Role of 670 
the N-Terminus of Budding Yeast Histone H3 Variant Cse4 in Ubiquitin-Mediated 671 
Proteolysis. Genetics 194: 513-518. 672 
Au, W. C., T. Zhang, P. K. Mishra, J. R. Eisenstatt, R. L. Walker et al., 2020 Skp, Cullin, F-box 673 
(SCF)-Met30 and SCF-Cdc4-Mediated Proteolysis of CENP-A Prevents Mislocalization 674 
of CENP-A for Chromosomal Stability in Budding Yeast. PLoS Genet 16: e1008597. 675 
Baker, S. P., J. Phillips, S. Anderson, Q. Qiu, J. Shabanowitz et al., 2010 Histone H3 Thr 45 676 
phosphorylation is a replication-associated post-translational modification in S. 677 
cerevisiae. Nat Cell Biol 12: 294-298. 678 
Baryshnikova, A., M. Costanzo, S. Dixon, F. J. Vizeacoumar, C. L. Myers et al., 2010 Synthetic 679 
genetic array (SGA) analysis in Saccharomyces cerevisiae and Schizosaccharomyces 680 
pombe. Methods Enzymol 470: 145-179. 681 
34 
 
Biggins, S., 2013 The Composition, Functions, and Regulation of the Budding Yeast 682 
Kinetochore. Genetics 194: 817-846. 683 
Boeckmann, L., Y. Takahashi, W. C. Au, P. K. Mishra, J. S. Choy et al., 2013 Phosphorylation 684 
of centromeric histone H3 variant regulates chromosome segregation in Saccharomyces 685 
cerevisiae. Mol Biol Cell 24: 2034-2044. 686 
Bonte, D., C. Lindvall, H. Liu, K. Dykema, K. Furge et al., 2008 Cdc7-Dbf4 Kinase 687 
Overexpression in Multiple Cancers and Tumor Cell Lines Is Correlated with p53 688 
Inactivation. Neoplasia 10: 920-931. 689 
Bruck, I., and D. Kaplan, 2009 Dbf4-Cdc7 Phosphorylation of Mcm2 is Required for Cell 690 
Growth. J Biol Chem 284: 28823-28831. 691 
Burrack, L. S., and J. Berman, 2012 Flexibility of centromere and kinetochore structures. Trends 692 
Genet 28: 204-212. 693 
Camahort, R., M. Shivaraju, M. Mattingly, B. Li, S. Nakanishi et al., 2009 Cse4 is part of an 694 
octameric nucleosome in budding yeast. Mol Cell 35: 794-805. 695 
Cheng, A. N., S. S. Jiang, C. C. Fan, Y. K. Lo, C. Y. Kuo et al., 2013 Increased Cdc7 expression 696 
is a marker of oral squamous cell carcinoma and overexpression of Cdc7 contributes to 697 
the resistance to DNA-damaging agents. Cancer Lett 337: 218-225. 698 
Cheng, H., X. Bao, X. Gan, S. Luo and H. Rao, 2017 Multiple E3s promote the degradation of 699 
histone H3 variant Cse4. Sci Rep 7: 8565. 700 
Cheng, H., X. Bao and H. Rao, 2016 The F-box Protein Rcy1 Is Involved in the Degradation of 701 
Histone H3 Variant Cse4 and Genome Maintenance. J Biol Chem 291: 10372-10377. 702 
Chereji, R. V., J. Ocampo and D. J. Clark, 2017 MNase-Sensitive Complexes in Yeast: 703 
Nucleosomes and Non-histone Barriers. Mol Cell 65: 565-577 e563. 704 
35 
 
Choy, J. S., P. K. Mishra, W. C. Au and M. A. Basrai, 2012 Insights into assembly and 705 
regulation of centromeric chromatin in Saccharomyces cerevisiae. Biochim Biophys Acta 706 
1819: 776-783. 707 
Ciftci-Yilmaz, S., W. C. Au, P. K. Mishra, J. R. Eisenstatt, J. Chang et al., 2018 A Genome-708 
Wide Screen Reveals a Role for the HIR Histone Chaperone Complex in Preventing 709 
Mislocalization of Budding Yeast CENP-A. Genetics 210: 203-218. 710 
Cole, H. A., J. Ocampo, J. R. Iben, R. V. Chereji and D. J. Clark, 2014 Heavy transcription of 711 
yeast genes correlates with differential loss of histone H2B relative to H4 and queued 712 
RNA polymerases. Nucleic Acids Res 42: 12512-12522. 713 
Collins, K. A., R. Camahort, C. Seidel, J. L. Gerton and S. Biggins, 2007 The overexpression of 714 
a Saccharomyces cerevisiae centromeric histone H3 variant mutant protein leads to a 715 
defect in kinetochore biorientation. Genetics 175: 513-525. 716 
Collins, K. A., S. Furuyama and S. Biggins, 2004 Proteolysis contributes to the exclusive 717 
centromere localization of the yeast Cse4/CENP-A histone H3 variant. Curr Biol 14: 718 
1968-1972. 719 
Costanzo, M., A. Baryshnikova, J. Bellay, Y. Kim, E. D. Spear et al., 2010 The genetic 720 
landscape of a cell. Science 327: 425-431. 721 
Costanzo, M., B. VanderSluis, E. N. Koch, A. Baryshnikova, C. Pons et al., 2016 A global 722 
genetic interaction network maps a wiring diagram of cellular function. Science 353. 723 
Crotti, L. B., and M. A. Basrai, 2004 Functional roles for evolutionarily conserved Spt4p at 724 
centromeres and heterochromatin in Saccharomyces cerevisiae. EMBO J 23: 1804-1814. 725 
Deyter, G. M., and S. Biggins, 2014 The FACT complex interacts with the E3 ubiquitin ligase 726 
Psh1 to prevent ectopic localization of CENP-A. Genes Dev 28: 1815-1826. 727 
36 
 
Fischböck-Halwachs, J., S. Singh, M. Potocnjak, G. Hagemann, V. Solis-Mezarino et al., 2019 728 
The COMA complex interacts with Cse4 and positions Sli15/Ipl1 at the budding yeast 729 
inner kinetochore. eLife 8. 730 
Gonzalez, M., H. He, Q. Dong, S. Sun and F. Li, 2014 Ectopic centromere nucleation by CENP--731 
a in fission yeast. Genetics 198: 1433-1446. 732 
Hardy, C. F. J., O. Dryga, S. Seematter, P. M. B. Pahl and R. A. Sclafani, 1997 mcm5/cdc46-733 
bob1 bypasses the requirement for the S phase activator Cdc7p. Proc. Natl. Acad. Sci. 734 
USA 94: 3151-3155. 735 
Henikoff, S., and T. Furuyama, 2012 The unconventional structure of centromeric nucleosomes. 736 
Chromosoma 121: 341-352. 737 
Heun, P., S. Erhardt, M. D. Blower, S. Weiss, A. D. Skora et al., 2006 Mislocalization of the 738 
Drosophila centromere-specific histone CID promotes formation of functional ectopic 739 
kinetochores. Dev Cell 10: 303-315. 740 
Hewawasam, G., M. Shivaraju, M. Mattingly, S. Venkatesh, S. Martin-Brown et al., 2010 Psh1 741 
is an E3 ubiquitin ligase that targets the centromeric histone variant Cse4. Mol Cell 40: 742 
444-454. 743 
Hewawasam, G. S., M. Mattingly, S. Venkatesh, Y. Zhang, L. Florens et al., 2014 744 
Phosphorylation by casein kinase 2 facilitates Psh1 protein-assisted degradation of Cse4 745 
protein. J Biol Chem 289: 29297-29309. 746 
Hildebrand, E. M., and S. Biggins, 2016 Regulation of Budding Yeast CENP-A levels Prevents 747 
Misincorporation at Promoter Nucleosomes and Transcriptional Defects. PLoS Genet 12: 748 
e1005930. 749 
37 
 
Hinshaw, S. M., and S. C. Harrison, 2019 The structure of the Ctf19c/CCAN from budding 750 
yeast. eLife 8. 751 
Hinshaw, S. M., V. Makrantoni, S. C. Harrison and A. l. Marston, 2017 The Kinetochore 752 
Receptor for the Cohesin Loading Complex. Cell 171: 72-84. 753 
Hoang, M. L., R. P. Leon, L. Pessoa-Brandao, S. Hunt, M. K. Raghuraman et al., 2007 Structural 754 
changes in Mcm5 protein bypass Cdc7-Dbf4 function and reduce replication origin 755 
efficiency in Saccharomyces cerevisiae. Mol Cell Biol 27: 7594-7602. 756 
Hollingsworth Jr, R. E., R. M. Ostroff, M. B. Klein, L. A. Niswander and R. A. Sclafani, 1992 757 
Molecular Genetic Studies of the Cdc7 Protein Kinase and Induced Mutagenesis in 758 
Yeast. Genetics 132: 53-62. 759 
Hou, Y., H. Q. Wang and Y. Ba, 2012 High expression of cell division cycle 7 protein correlates 760 
with poor prognosis in patients with diffuse large B-cell lymphoma. Med Oncol 29: 761 
3498-3503. 762 
Jackson, A. L., P. M. B. Pahl, K. Harrison, J. Rosamond and R. A. Sclafani, 1993 Cell Cycle 763 
Regulation of the Yeast Cdc7 Protein Kinase by 764 
Association with the Dbf4 Proteint. Molecular and Cellular Biology 13: 2899-2908. 765 
Kastenmayer, J. P., L. Ni, A. Chu, L. E. Kitchen, W. C. Au et al., 2006 Functional genomics of 766 
genes with small open reading frames (sORFs) in S. cerevisiae. Genome Res 16: 365-767 
373. 768 
Kulkarni, A. A., S. R. Kingsbury, S. Tudzarova, H. K. Hong, M. Loddo et al., 2009 Cdc7 kinase 769 
is a predictor of survival and a novel therapeutic target in epithelial ovarian carcinoma. 770 
Clin Cancer Res 15: 2417-2425. 771 
38 
 
Lacoste, N., A. Woolfe, H. Tachiwana, A. V. Garea, T. Barth et al., 2014 Mislocalization of the 772 
centromeric histone variant CenH3/CENP-A in human cells depends on the chaperone 773 
DAXX. Mol Cell 53: 631-644. 774 
Lefrancois, P., G. M. Euskirchen, R. K. Auerbach, J. Rozowsky, T. Gibson et al., 2009 Efficient 775 
yeast ChIP-Seq using multiplex short-read DNA sequencing. BMC Genomics 10. 776 
Lei, M., Y. Kawasaki, M. R. Young, M. Kihara, A. Sugino et al., 1997 Mcm2 is a target of 777 
regulation by Cdc7-Dbf4 during the initiation of DNA synthesis. Genes Dev 11: 3365-778 
3374. 779 
Li, Y., Z. Zhu, S. Zhang, D. Yu, H. Yu et al., 2011 ShRNA-targeted centromere protein A 780 
inhibits hepatocellular carcinoma growth. PLoS One 6: e17794. 781 
Maddox, P. S., K. D. Corbett and A. Desai, 2012 Structure, assembly and reading of centromeric 782 
chromatin. Curr Opin Genet Dev 22: 139-147. 783 
McGovern, S. L., Y. Qi, L. Pusztai, W. F. Symmans and T. A. Buchholz, 2012 Centromere 784 
protein-A, an essential centromere protein, is a prognostic marker for relapse in estrogen 785 
receptor-positive breast cancer. Breast Cancer Res 14: R72. 786 
McKinley, K. L., and I. M. Cheeseman, 2016 The molecular basis for centromere identity and 787 
function. Nat Rev Mol Cell Biol 17: 16-29. 788 
Mishra, P. K., W. C. Au, J. S. Choy, P. H. Kuich, R. E. Baker et al., 2011 Misregulation of 789 
Scm3p/HJURP causes chromosome instability in Saccharomyces cerevisiae and human 790 
cells. PLoS Genet 7: e1002303. 791 
Montagnoli, A., P. Tenca, F. Sola, D. Carpani, D. Brotherton et al., 2004 Cdc7 inhibition reveals 792 
a p53-dependent replication checkpoint that is defective in cancer cells. Cancer Res 63: 793 
7110-7116. 794 
39 
 
Moreno-Moreno, O., S. Medina-Giro, M. Torras-Llort and F. Azorin, 2011 The F box protein 795 
partner of paired regulates stability of Drosophila centromeric histone H3, CenH3(CID). 796 
Curr Biol 21: 1488-1493. 797 
Moreno-Moreno, O., M. Torras-Llort and F. Azorin, 2006 Proteolysis restricts localization of 798 
CID, the centromere-specific histone H3 variant of Drosophila, to centromeres. Nucleic 799 
Acids Res 34: 6247-6255. 800 
Nagalakshmi, U., Z. Wang, K. Waern, C. Shou, D. Raha et al., 2008 The Transcriptional 801 
Landscape of the Yeast Genome Defined by RNA Sequencing. Science 320: 1344-1349. 802 
Natsume, T., C. A. Muller, Y. Katou, R. Retkute, M. Gierlinski et al., 2013 Kinetochores 803 
coordinate pericentromeric cohesion and early DNA replication by Cdc7-Dbf4 kinase 804 
recruitment. Mol Cell 50: 661-674. 805 
Ohkuni, K., R. Levy-Myers, J. Warren, W. C. Au, Y. Takahashi et al., 2018 N-terminal 806 
Sumoylation of Centromeric Histone H3 Variant Cse4 Regulates Its Proteolysis To 807 
Prevent Mislocalization to Non-centromeric Chromatin. G3 (Bethesda) 8: 1215-1223. 808 
Ohkuni, K., Y. Takahashi, A. Fulp, J. Lawrimore, W. C. Au et al., 2016 SUMO-Targeted 809 
Ubiquitin Ligase (STUbL) Slx5 regulates proteolysis of centromeric histone H3 variant 810 
Cse4 and prevents its mislocalization to euchromatin. Mol Biol Cell. 811 
Oshiro, G., J. C. Owens, Y. Shellman, R. A. Sclafani and J. J. Li, 1999 Cell cycle control of 812 
Cdc7p kinase activity through regulation of Dbf4p stability. Mol Cell Biol 19: 4888-813 
4896. 814 
Owens, J. C., C. S. Detweller and J. J. Li, 1997 CDC45 is required in conjunction with 815 
CDC7/DBF4 to trigger the initiation of DNA replication. Proc Natl Acad Sci U S A 94: 816 
12521-12526. 817 
40 
 
Pessoa-Brandao, L., and R. A. Sclafani, 2004 CDC7/DBF4 functions in the translesion synthesis 818 
branch of the RAD6 epistasis group in Saccharomyces cerevisiae. Genetics 167: 1597-819 
1610. 820 
Pinsky, B. A., S. Y. Tatsutani, K. A. Collins and S. Biggins, 2003 An Mtw1 complex promotes 821 
kinetochore biorientation that is monitored by the Ipl1/Aurora protein kinase. Dev Cell 5: 822 
735-745. 823 
Przewloka, M. R., and D. M. Glover, 2009 The kinetochore and the centromere: a working long 824 
distance relationship. Annu Rev Genet 43: 439-465. 825 
Raghuraman, M. K., E. A. Winzeler, D. Collingwood, S. Hunt, L. Wodicka et al., 2001 826 
Replication Dynamics of the Yeast Genome. Science 294: 115-121. 827 
Ranjitkar, P., M. O. Press, X. Yi, R. Baker, M. J. MacCoss et al., 2010 An E3 ubiquitin ligase 828 
prevents ectopic localization of the centromeric histone H3 variant via the centromere 829 
targeting domain. Mol Cell 40: 455-464. 830 
Robinson, J. T., H. Thorvaldsdottir, W. Winckler, M. Guttman, E. S. Lander et al., 2011 831 
Integrative genomics viewer. Nat Biotechnol 29: 24-26. 832 
Rodriguez-Acebes, S., I. Proctor, M. Loddo, A. Wollenschlaeger, M. Rashid et al., 2010 833 
Targeting DNA replication before it starts: Cdc7 as a therapeutic target in p53-mutant 834 
breast cancers. Am J Pathol 177: 2034-2045. 835 
Rossbach, D., D. S. Bryan, J. R. Hesselberth and R. Sclafani, 2017 Localization of Cdc7 Protein 836 
Kinase During DNA Replication in Saccharomyces cerevisiae. G3 7: 3757-3774. 837 
Rossbach, D., and R. A. Sclafani, 2016 CDC7/DBF4 functions in the translesion synthesis 838 
branch of the RAD6 epistasis group in Saccharomyces cerevisiae, pp. 279-296 in The 839 
41 
 
Initiation of DNA Replication in Eukaryotes, edited by D. L. Kaplan. Springer 840 
International Publishing, New York. 841 
Sclafani, R. A., 2000 Cdc7p-Dbf4p becomes famous in the cell cycle. Journal of Cell Science 842 
113: 2111-2117. 843 
Sclafani, R. A., M. Tecklenburg and A. Pierce, 2002 The mcm5-bob1 Bypass of Cdc7p/Dbf4p in 844 
DNA Replication Depends on Both Cdk1-Independent and Cdk1-Dependent Steps in 845 
Saccharomyces cerevisiae. Genetics 161: 47-57. 846 
Shrestha, R. L., G. S. Ahn, M. I. Staples, K. M. Sathyan, T. S. Karpova et al., 2017 847 
Mislocalization of centromeric histone H3 variant CENP-A contributes to chromosomal 848 
instability (CIN) in human cells. Oncotarget 8: 46781-46800. 849 
Stillman, B., 1996 Cell Cycle Control of DNA Replication. Science 274: 1659-1663. 850 
Sun, X., P. L. Clermont, W. Jiao, C. D. Helgason, P. W. Gout et al., 2016 Elevated expression of 851 
the centromere protein-A(CENP-A)-encoding gene as a prognostic and predictive 852 
biomarker in human cancers. Int J Cancer 139: 899-907. 853 
Tomonaga, T., K. Matsushita, S. Yamaguchi, T. Oohashi, H. Shimada et al., 2003 854 
Overexpression and mistargeting of centromere protein-A in human primary colorectal 855 
cancer. Cancer Res 63: 3511-3516. 856 
Verdaasdonk, J. S., and K. Bloom, 2011 Centromeres: unique chromatin structures that drive 857 
chromosome segregation. Nat Rev Mol Cell Biol 12: 320-332. 858 
Weinreich, M., and B. Stillman, 1999 Cdc7p-Dbf4p kinase binds to chromatin during S phase 859 
and is regulated by both the APC and the RAD53 checkpoint pathway. EMBO J 18: 860 
5334-5346. 861 
42 
 
Westermann, S., I. M. Cheeseman, S. Anderson, J. R. Yates, 3rd, D. G. Drubin et al., 2003 862 
Architecture of the budding yeast kinetochore reveals a conserved molecular core. J Cell 863 
Biol 163: 215-222. 864 
Wong, C. Y. Y., B. C. H. Lee and K. W. Y. Yuen, 2020 Epigenetic regulation of centromere 865 
function. Cell Mol LIfe Sci. 866 
Zhang, W., J. H. Mao, W. Zhu, A. K. Jain, K. Liu et al., 2016 Centromere and kinetochore gene 867 
misexpression predicts cancer patient survival and response to radiotherapy and 868 
chemotherapy. Nat Commun 7: 12619. 869 
Zhang, Y., T. Liu, C. A. Meyer, J. Eeckhoute, D. S. Johnson et al., 2008 Model-based Analysis 870 
of ChIP-Seq (MACS). Genome Biology 9: R137. 871 
Zou, L., and B. Stillman, 2000 Assembly of a complex containing Cdc45p, replication protein A, 872 
and Mcm2p at replication origins controlled by S-phase cyclin-dependent kinases and 873 
Cdc7p-Dbf4p kinase. Mol Biol Cell 20: 3086-3096. 874 
 875 
A B 
vector 
GALCSE4 
Glucose Galactose 
vector 
GALCSE4 
vector 
GALCSE4 
vector 
GALCSE4 
WT 
cdc7-4 
WT 
cdc7-7 
vector 
GALCSE4 
vector 
GALCSE4 
dbf4-1 
dbf4-2 
__ __ 
__ + 
+ __ 
+ + 
__ __ 
__ + 
+ __ 
+ + 
23°C 
Glucose Galactose 
cd
c7
-7
 
37°C 
GAL 
CSE4 
 
CDC7 
cd
c7
-7
 
23°C 
Figure 1 
A C WT cdc7-7 
0    30   60  90  120  0   30  60   90  120 min CHX  
HA (Cse4) 
Tub2 
0  30  60  90 120   0   30   60  90  120 min CHX 
WT dbf4-1 
HA (Cse4) 
Tub2 
B 
R
el
at
iv
e
 C
se
4
-U
b
iq
u
it
in
at
io
n
wt cdc7-7
0
1
2
3
p < 0.05
WT cdc7-7 
p < 0.05 
HA 
(Cse4) 
Input 
Pull down: 
Ub+ 
W
T 
cd
c7
-7
 
W
T 
cd
c7
-7
 
U
b
n
-C
se
4
 
38- 
49 - 
62 - 
kDa 
Figure 2 
cdc7-7 
WT 
0 30 60 90 120
0
50
100
Time (minutes)
H
A
/T
u
b
2
 N
o
rm
al
iz
e
d
 t
o
 0
 m
in
wild type
cdc7-7
dbf4-1 
WT 
0 30 60 90 120
0
50
100
Time (minutes)
H
A
/T
u
b
2 
N
o
rm
al
iz
ed
 t
o
 0
 m
in
wild type
dbf4-1
A B 
vector 
vector 
vector 
GALCSE4 
GALCSE4 
GALCSE4 
cdc7-7 
mcm5-bob1 
cdc7-7 
WT 
mcm5-bob1 
vector 
GALCSE4 
Glucose Galactose 
0      30    60   90 
WT cdc7-7 
min CHX 
Tub2 
HA (Cse4) 
0      30     60    90 0      30      60    90 0     30     60     90 
cdc7-7 mcm5-bob1 mcm5-bob1 
cdc7-7 
WT 
cdc7-7 mcm5-bob1 
mcm5-bob1 
23°C 
Figure 3 
0 30 60 90
0
50
100
Time (minutes)
H
A
/T
u
b
2
 N
o
rm
al
iz
e
d
 t
o
 0
 m
in
wild type
cdc7-7
mcm5-bob1
cdc7-7 mcm5- ob1
WT 
cdc7-7 
DAPI HA-Cse4 Merge 
A B 
1 
or
 2
 Fo
ci
3+
 Fo
ci
1 
or
 2
 Fo
ci
3+
 Fo
ci
0
20
40
60
80
100
%
 C
e
ll
s
 w
it
h
 C
s
e
4
 f
o
c
i
wt cdc7-7
cdc7-7 WT 
n=105 n=106 
p = 0.0028 
p = 0.0028 
1 
or
 2
 Fo
ci
3+
 Fo
ci
1 
or
 2
 Fo
ci
3+
 Fo
ci
0
20
40
60
80
100
%
 C
e
ll
s 
w
it
h
 M
tw
1
-G
FP
 f
o
ci
wt cdc7-7
n=123 n=126 
WT cdc7-7 
p = 0.1683 
p = 0.1683 
C 
Figure 4 
D 
WT 
cdc7-7 
GFP 
Peak Annotations 
in cdc7-7 GALCSE4 
Number 
of Peaks 
% of 
Total 
Total Size 
(bp) 
Enrichment 
(Obs/Exp) 
LogP Enrichment 
(+values depleted) 
3’ UTR 28 1.3% 868412 0.2222 60.544 
Transcription 
Termination Site 
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Total 2203 15178135 
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